ITGB1 and non-small cell lung carcinoma: In conclusion, our results suggest that ITGB1 promotes EMT by targeting YAP1 and influences the DNA damage response by affecting cell cycle checkpoints, apoptosis, and ATM/CHK2 signalling, whereas inhibiting ITGB1 reverses those effects and improves NSCLC radiosensitivity.